Sorry, no content matched your criteria.
High Dose Influenza Vaccine
All adults 65 years of age and older are advised to receive an annual influenza vaccine, according to Canada’s National Advisory Committee on Immunization (NACI), as this age group is considered to be at particularly high-risk of influenza-related complications or hospitalization. FLUZONE® High-Dose vaccine, developed for adults 65 years of age and older has shown […]